Filtered By:
Condition: Rosacea
Drug: Tetracycline
This page shows you your search results in order of date.
Order by Relevance | Date
Total 78 results found since Jan 2013.
Clinical and histological features and treatment outcomes of patients with Morbihan disease: a systematic review
AbstractMorbihan disease (MD) is considered a rare complication of rosacea, which is difficult to diagnose and challenging to treat. Here, we performed a systematic review of available case reports and case series to summarize key clinical and pathologic features of and successful treatment regimens for MD. We conducted a search of the PubMed/MEDLINE, EMBASE, and Cochrane electronic databases from their inception to the date of search on March 6, 2023. We found that MD affects patients in the fifth decade of life on average, more commonly reported in male than female (69% vs 31%). Clinically, MD affects the eyelids, cheeks...
Source: Archives of Dermatological Research - August 30, 2023 Category: Dermatology Source Type: research
Sarecycline: A Narrow-Spectrum Antibiotic
Skin Therapy Lett. 2022 May;27(3):5-7.ABSTRACTTetracycline-class drugs have been used for first-line treatment of moderate-to-severe acne and rosacea for decades. Recently, a new third generation tetracycline, sarecycline, was US FDA-approved for the treatment of moderate-to-severe acne. This narrow-spectrum tetracycline-derived antibiotic has been shown to be effective with an improved safety profile.PMID:35533371
Source: Skin Therapy Letter - May 9, 2022 Category: Dermatology Authors: Susuana Adjei Austinn C Miller Laurie A Temiz Stephen K Tyring Source Type: research
